Clinical trial
Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on…
NCT00403520 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00403520 |
|---|---|
| Title | Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers |
| Official title | Assessment of the Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers in Patients With Mild Cognitive Disorders |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Experimental 1, Placebo Comparator |
| Enrollment | 240 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Aug 1, 2010 |
| First posted | Nov 23, 2006 |
| Last update posted | Jul 14, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: